NCT03494348

Brief Summary

The aim of this study is to evaluate, over a 2 year period, the migration pattern, function and the possibility of anatomical reconstruction of a relatively new total knee arthroplasty (TKA) concept, the Persona. Sixty patients will be randomized into 2 groups of 30 patients each, with one group receiving the Persona TKA with a conventional Cruciate Retaining (CR) polyethylene articular surface and the other group with a newly developed Medial Congruent (MC) articular surface. Patients will be followed up with Radiostereometry (RSA), conventional radiography, outcome questionnaires, clinical evaluation and Computer Tomography (CT). The migration pattern of the components will be evaluated as well as the degree of anatomical reconstruction and clinical result. We plan also to do a 5 year follow-up of the patients with RSA and PROMS.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2017

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2017

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

April 3, 2018

Completed
8 days until next milestone

First Posted

Study publicly available on registry

April 11, 2018

Completed
2.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 30, 2020

Completed
3.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2023

Completed
Last Updated

November 29, 2022

Status Verified

November 1, 2022

Enrollment Period

3.1 years

First QC Date

April 3, 2018

Last Update Submit

November 22, 2022

Conditions

Keywords

Radiostereometry (RSA)Total Knee Arthroplasty

Outcome Measures

Primary Outcomes (1)

  • Radiostereometry (RSA)

    Measure the change in component migration over time (translation and rotation around the x-, y- and z-axis)

    First postoperative day, 3 months, 1 year, 2 years and 5 years

Secondary Outcomes (4)

  • Computer Tomography (CT)

    Preoperatively and 3 months postoperatively

  • Conventional radiography

    Preoperatively and 3 months postoperatively

  • General health questionnaire

    Preoperatively, 1, 2 and 5 years postoperatively

  • Knee specific health questionnaire

    Preoperatively, 1, 2 and 5 years postoperatively

Study Arms (2)

Cruciate Retaining Polyethylene (CR)

NO INTERVENTION

This is the standard Polyethylene articular surface

Medial Congruent Polyethylene (MC)

ACTIVE COMPARATOR

The intervention here will be the MC articular surface. This is the new Polyethylene articular surface with a more congruent medial side and a more flat lateral side which should better resemble natural anatomy.

Device: Medial Congruent Polyethylene (MC)

Interventions

One group receives the conventional CR surface and the other the new MC articular surface

Also known as: MC
Medial Congruent Polyethylene (MC)

Eligibility Criteria

Age50 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Osteoarthritis of the knee necessitating knee replacement
  • ASA I-III
  • BMI 18 - 35

You may not qualify if:

  • Joint sepsis in history
  • immunosuppresive drugs last 5 years
  • Rheumatoid arthritis
  • Severe osteoporosis or other metabolic bone diseases
  • Neuromuscular diseases
  • Personal disorders suspected of limiting rehab and completion of the trial period
  • Previous osteotomy of affected limb
  • Intra-articular knee fracture of affected limb
  • Peroperative fracture
  • Severe deformity of affected joint in need of augmentation or excessive release
  • Obvious need for more constrained knee than CR

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Orthopedics, Skane University Hospital, Lund University

Lund, 22185, Sweden

Location

MeSH Terms

Conditions

Osteoarthritis, Knee

Condition Hierarchy (Ancestors)

OsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Study Officials

  • Gunnar Flivik, MD PhD

    Dept of Orthopedics, Skåne University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 3, 2018

First Posted

April 11, 2018

Study Start

October 1, 2017

Primary Completion

October 30, 2020

Study Completion

December 1, 2023

Last Updated

November 29, 2022

Record last verified: 2022-11

Locations